Sep 26, 2023 / 03:05PM GMT
Charles Duncan Cantor Fitzgerald-Analyst
I think we'll get started with the next presenting company from the Cantor Global Health Care Conference for 2023. I am Charles Duncan. I'm a senior biotechnology analyst for the firm, not referring to my age, but the number of companies I cover and how long I've covered them.
One of the companies that I've had the pleasure of covering for many years is Catalyst Pharmaceuticals, and I've seen it be transformed from a development-stage company to a commercial-stage company that seeks to really do well by doing right by patients to a company that has real business and has not only a growing revenue stream, which is profitable, but also has started to bring in other growth drivers, other pipeline candidates.
So it's a pleasure to introduce two people from the management of Catalyst Pharmaceuticals. Dr. Steven Miller, the company's Chief Operating Officer and Chief Scientific Officer. Steven, great to see you. Thank you for joining us. And Mr. Pat McEnany, the company's Co-Founder, President, and CEO. And it's just really great to have these
Catalyst Pharmaceuticals Inc at Cantor Fitzgerald Global Healthcare Conference Transcript
Feb 06, 2024
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers